These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31217023)

  • 1. Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy.
    Keshavarz M; Solaymani-Mohammadi F; Miri SM; Ghaemi A
    J Biomed Sci; 2019 Jun; 26(1):48. PubMed ID: 31217023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.
    Tazawa H; Kuroda S; Hasei J; Kagawa S; Fujiwara T
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between oncolytic viruses and autophagy in cancer therapy.
    Jin KT; Tao XH; Fan YB; Wang SB
    Biomed Pharmacother; 2021 Feb; 134():110932. PubMed ID: 33370632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic adenovirus-induced autophagy: tumor-suppressive effect and molecular basis.
    Tazawa H; Kagawa S; Fujiwara T
    Acta Med Okayama; 2013; 67(6):333-42. PubMed ID: 24356717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncolytic Paramyxoviruses: Mechanism of Action, Preclinical and Clinical Studies].
    Matveeva OV; Kochneva GV; Zainutdinov SS; Ilyinskaya GV; Chumakov PM
    Mol Biol (Mosk); 2018; 52(3):360-379. PubMed ID: 29989571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response.
    Wu YY; Sun TK; Chen MS; Munir M; Liu HJ
    Front Cell Infect Microbiol; 2023; 13():1142172. PubMed ID: 37009515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
    Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage response to oncolytic paramyxoviruses potentiates virus-mediated tumor cell killing.
    Tan DQ; Zhang L; Ohba K; Ye M; Ichiyama K; Yamamoto N
    Eur J Immunol; 2016 Apr; 46(4):919-28. PubMed ID: 26763072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies.
    Workenhe ST; Mossman KL
    Mol Ther; 2014 Feb; 22(2):251-256. PubMed ID: 24048442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer.
    Ma J; Ramachandran M; Jin C; Quijano-Rubio C; Martikainen M; Yu D; Essand M
    Cell Death Dis; 2020 Jan; 11(1):48. PubMed ID: 31969562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients.
    Liikanen I; Ahtiainen L; Hirvinen ML; Bramante S; Cerullo V; Nokisalmi P; Hemminki O; Diaconu I; Pesonen S; Koski A; Kangasniemi L; Pesonen SK; Oksanen M; Laasonen L; Partanen K; Joensuu T; Zhao F; Kanerva A; Hemminki A
    Mol Ther; 2013 Jun; 21(6):1212-23. PubMed ID: 23546299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia.
    Tong Y; You L; Liu H; Li L; Meng H; Qian Q; Qian W
    Oncotarget; 2013 Jun; 4(6):860-74. PubMed ID: 23765161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on Vaxinia virus: an immuno-oncolytic vector in cancer therapy.
    Kaur SD; Singh AD; Kapoor DN
    Med Oncol; 2023 Jun; 40(7):205. PubMed ID: 37318642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncolytic virus ΔPK has multimodal anti-tumor activity.
    Aurelian L; Bollino D; Colunga A
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27242376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose VitC plus oncolytic adenoviruses enhance immunogenic tumor cell death and reprogram tumor immune microenvironment.
    Ma J; Zhang C; Shi G; Yue D; Shu Y; Hu S; Qi Z; Chen Y; Zhang B; Zhang Y; Huang A; Su C; Zhang Y; Deng H; Cheng P
    Mol Ther; 2022 Feb; 30(2):644-661. PubMed ID: 34547462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions.
    Kim J; Hall RR; Lesniak MS; Ahmed AU
    Viruses; 2015 Nov; 7(12):6200-17. PubMed ID: 26633462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer].
    Kochneva GV; Sivolobova GF; Tkacheva AV; Gorchakov AA; Kulemzin SV
    Mol Biol (Mosk); 2020; 54(1):3-16. PubMed ID: 32163385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
    Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW
    Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing therapeutic efficacy of oncolytic vaccinia virus armed with Beclin-1, an autophagic Gene in leukemia and myeloma.
    Lei W; Wang S; Xu N; Chen Y; Wu G; Zhang A; Chen X; Tong Y; Qian W
    Biomed Pharmacother; 2020 May; 125():110030. PubMed ID: 32187960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells.
    Hasei J; Sasaki T; Tazawa H; Osaki S; Yamakawa Y; Kunisada T; Yoshida A; Hashimoto Y; Onishi T; Uno F; Kagawa S; Urata Y; Ozaki T; Fujiwara T
    Mol Cancer Ther; 2013 Mar; 12(3):314-25. PubMed ID: 23315976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.